| Patents for A01K 67 - Rearing or breeding animals, not otherwise provided for; New breeds of animals (34,042) |
|---|
| 01/11/2001 | CA2376166A1 Control of gene expression |
| 01/11/2001 | CA2372742A1 Double transgenic animals as models for neurodegenerative disease |
| 01/10/2001 | EP1066802A2 Injector of sperm or of a fertilized ovum into a domestic animal and method of operation thereof |
| 01/10/2001 | EP1066395A1 Inducible alphaviral gene expression system |
| 01/10/2001 | EP1066392A1 Vectors for gene mutagenesis and gene discovery |
| 01/10/2001 | EP1066378A2 Lyst protein complexes and lyst interacting proteins |
| 01/10/2001 | EP1066324A1 Novel mammalian g-protein coupled receptors having extracellular leucine rich repeat regions |
| 01/10/2001 | EP1066315A1 Use of inhibitors of mammalian asparaginyl endopeptidase for therapy of autoimmune disease |
| 01/10/2001 | EP1066311A1 Compositions and methods for the identification of lung tumor cells |
| 01/10/2001 | EP1066051A1 Sciellin and uses thereof |
| 01/10/2001 | EP0730643B1 Transgenic animals harboring app allele having swedish mutation |
| 01/10/2001 | EP0701607B1 Preparation and use of transgenic mice lacking expression of cd28 |
| 01/09/2001 | US6172278 Ikaros transgenic cells and mice |
| 01/09/2001 | US6172277 Inducing amyloid plaque deposition in rodent brain; infusing brain of rodent with solution comprising amyloid peptide, detecting amplified amount of amyloid plaque formation in the brain of rodent compare to control |
| 01/09/2001 | US6172194 ARF-p19, a novel regulator of the mammalian cell cycle |
| 01/04/2001 | WO2001001150A2 Diagnostic test for thrombotic or thromboembolic disease |
| 01/04/2001 | WO2001000860A2 Prolactin-inducible mammary specific promoter |
| 01/04/2001 | WO2001000855A1 Fusion proteins incorporating lysozyme |
| 01/04/2001 | WO2001000851A1 Cyclic amp phosphodiesterase isoforms and methods of use |
| 01/04/2001 | WO2001000822A2 Cdna sequences of two interacting fancip2 and fancip3 of the fanconi anemia complementation group a protein |
| 01/04/2001 | WO2001000795A1 A method for producing cloned cows |
| 01/04/2001 | WO2001000794A1 Method for producing cloned tigers by employing inter-species nuclear transplantation technique |
| 01/04/2001 | WO2001000793A1 Method for producing human cloned embryos by employing inter-species nuclear transplantation technique |
| 01/04/2001 | WO2001000650A1 Cytoplasmic transfer to de-differentiate recipient cells |
| 01/04/2001 | WO2001000244A2 METHODS OF TREATMENT USING ANTI-ErbB ANTIBODY-MAYTANSINOID CONJUGATES |
| 01/04/2001 | WO2001000015A1 Goodpasture's syndrome model mouse |
| 01/04/2001 | WO2001000014A2 Test animal for atherosclerosis model and methods for testing and screening |
| 01/04/2001 | WO2000061069A3 Methods and compositions for use in the treatment of hyperlipidemia |
| 01/04/2001 | CA2377515A1 Cytoplasmic transfer to de-differentiate recipient cells |
| 01/04/2001 | CA2377484A1 Cyclic amp phosphodiesterase isoforms and methods of use |
| 01/04/2001 | CA2372700A1 Diagnostic test for thrombotic or thromboembolic disease |
| 01/04/2001 | CA2334954A1 A method for producing cloned tigers by employing inter-species nuclear transplantation technique |
| 01/04/2001 | CA2334953A1 Method for producing human cloned embryos by employing inter-species nuclear transplantation technique |
| 01/04/2001 | CA2334382A1 Method for producing cloned cows |
| 01/03/2001 | EP1064394A1 Method for ballistic transformation of caenorhabditis elegans |
| 01/03/2001 | EP1064367A2 Production of biofilaments in transgenic animals |
| 01/03/2001 | EP1064013A1 $i(IN VITRO) FORMATION OF CONGOPHILIC MALTESE-CROSS AMYLOID PLAQUES TO IDENTIFY ANTI-PLAQUE THERAPEUTICS FOR THE TREATMENT OF ALZHEIMER'S AND PRION DISEASES |
| 12/28/2000 | WO2000079264A1 System and method to detect compounds and mutations that upregulate and downregulate expression of nucleotide sequences |
| 12/28/2000 | WO2000078940A1 In vivo insect model system for type-2 diabetes |
| 12/28/2000 | WO2000078930A1 Method for enhancing hematopoiesis |
| 12/28/2000 | WO2000078119A2 Cardiomyocytes with enhanced proliferative potential |
| 12/28/2000 | CA2377270A1 Cardiomyocytes with enhanced proliferative potential |
| 12/28/2000 | CA2375527A1 Method for enhancing hematopoiesis |
| 12/28/2000 | CA2375484A1 In vivo insect model system for type-2 diabetes |
| 12/27/2000 | EP1063298A2 Transgenic Animal Model for Alzheimer Disease |
| 12/27/2000 | EP1063292A2 DNA encoding human alpha 1 adrenergic receptors and uses thereof |
| 12/27/2000 | EP1063291A2 DNA encoding human alpha 1 adrenergic receptors and uses thereof |
| 12/27/2000 | EP1062329A1 Introduction of nucleic acid into skin cells by topical application |
| 12/27/2000 | EP1062326A1 Glycosyl sulfotransferase-3 |
| 12/27/2000 | EP1061798A1 Non-human transgenic mammal, method for producing same and its use |
| 12/27/2000 | EP0830607A4 Selection of livestock using igf levels |
| 12/27/2000 | CN1278299A Transgenic animals for xenotransplantation with reduced antibody-mediated rejection |
| 12/26/2000 | US6166288 Method of producing transgenic animals for xenotransplantation expressing both an enzyme masking or reducing the level of the gal epitope and a complement inhibitor |
| 12/26/2000 | US6166287 Screening for modulators useful in the treatment of cushing's syndrome and anxiety; administering modulators to transgenic rodent, monitoring expression of protein in preferential hypothalmus cells, compare to wild-type expression |
| 12/26/2000 | US6166180 Polypeptide for the treatment of genetic disorders associated with transmembrane protein |
| 12/26/2000 | US6166178 Polypeptide for the treatment of cancer; anticarcinogenic agents |
| 12/26/2000 | US6165747 Comprise morphogenic signals produced by tissue patterning centers, and are involved in the formation of ordered spatial arrangements of differentiated tissues in vertebrates |
| 12/21/2000 | WO2000077232A1 Promoters from atlantic salmon |
| 12/21/2000 | WO2000077208A2 Gustatory receptors in drosophila |
| 12/21/2000 | WO2000077207A2 Nucleic acid encoding proteins involved in protein degradation, products and methods related thereto |
| 12/21/2000 | WO2000077199A1 Cloning and expression of a novel 5-ht4 receptor |
| 12/21/2000 | WO2000077189A2 Method for the neogenesis of cell age |
| 12/21/2000 | WO2000077168A2 ANTAGONISTS OF BMP AND TGFβ SIGNALLING PATHWAYS |
| 12/21/2000 | WO2000077035A2 Novel potassium channels and genes encoding these potassium channels |
| 12/21/2000 | WO2000076310A1 Transgenic animals for producing specific isotypes of human antibodies via non-cognate switch regions |
| 12/21/2000 | WO2000076309A2 Non-human transgenic animals deficient in gas6 function and their use |
| 12/21/2000 | WO2000076308A1 Animal models and methods for analysis of lipid metabolism and screening of pharmaceutical and pesticidal agents that modulate lipid metabolism |
| 12/21/2000 | WO2000051647A3 Animal model of allergies |
| 12/21/2000 | WO2000046240A3 Polypeptides involved in immune response |
| 12/21/2000 | WO2000040701A3 Non-myeloablative tolerogenic treatment |
| 12/21/2000 | CA2751621A1 Hybridomas that undergo class-switching in vitro |
| 12/21/2000 | CA2376675A1 Antagonists of bmp and tgf.beta. signalling pathways |
| 12/21/2000 | CA2376389A1 Cloning and expression of a novel 5-ht4 receptor |
| 12/21/2000 | CA2376243A1 Gustatory receptors in drosophila |
| 12/21/2000 | CA2375423A1 Promoters from atlantic salmon |
| 12/21/2000 | CA2373628A1 Animal models and methods for analysis of lipid metabolism and screening of pharmaceutical and pesticidal agents that modulate lipid metabolism |
| 12/20/2000 | EP1060244A1 Pluripotent embryonic stem cells and methods of obtaining them |
| 12/19/2000 | US6162963 Generation of Xenogenetic antibodies |
| 12/14/2000 | WO2000075347A2 Tet repressor-based transcriptional regulatory proteins |
| 12/14/2000 | WO2000075342A1 Novel plasmid vector |
| 12/14/2000 | WO2000075341A1 Δ6-acetylenase and δ6-desaturase from ceratodon purpureus |
| 12/14/2000 | WO2000075311A1 Recombinant nematode nicotinic receptor and uses |
| 12/14/2000 | WO2000075300A2 Methods for manipulating the avian genome |
| 12/14/2000 | WO2000075288A1 Transgenic decapods, decapod cell lines and methods of producing same |
| 12/14/2000 | WO2000075278A2 Gene encoding nade, p75ntr-associated cell death executor and uses thereof |
| 12/14/2000 | WO2000074706A1 Therapeutic use of an inhibitor of a hedgehog or a hedgehog-related signalling pathway |
| 12/14/2000 | WO2000074693A2 Immunity generation |
| 12/14/2000 | WO2000074478A1 Method and device for rearing insects, especially for obtaining a secretion from fly larvae for therapeutic application |
| 12/14/2000 | WO2000074477A1 Process for reconstructing a non-human animal embryo by nuclear transfer and preparing the animal therefrom, and embryos and animals obtained thereby |
| 12/14/2000 | WO2000053776A3 Human kallikrein-like genes |
| 12/14/2000 | WO2000053775A3 Prevention and treatment of viral infections |
| 12/14/2000 | WO2000050562A3 Dna encoding snorf25 receptor |
| 12/14/2000 | WO2000043032A3 Baff, inhibitors thereof and their use in the modulation of b-cell response |
| 12/14/2000 | DE19925996A1 Verfahren und Vorrichtung zur Herstellung des Sekrets von Fliegenlarven für die therapeutische Applikation Method and apparatus for the production of the secretion of the fly larvae for therapeutic application |
| 12/14/2000 | CA2376665A1 Novel tet repressor-based transcriptional regulatory proteins |
| 12/14/2000 | CA2376642A1 Recombinant nematode nicotinic receptor and uses |
| 12/14/2000 | CA2376210A1 Therapeutic use of an inhibitor of a hedgehog or a hedgehog-related signalling pathway |
| 12/14/2000 | CA2375441A1 Methods for manipulating the avian genome |
| 12/14/2000 | CA2373277A1 Immunity generation |
| 12/13/2000 | EP1058500A1 The helios gene |